-
- Medicines
Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval
– UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapy
– Highly experienced team ready to support ATMP innovators at all stages
– Offering comprehensive range of services from early process and analytical development through cGMP manufacturing for clinical t…